SE0201661D0 - New salts - Google Patents
New saltsInfo
- Publication number
- SE0201661D0 SE0201661D0 SE0201661A SE0201661A SE0201661D0 SE 0201661 D0 SE0201661 D0 SE 0201661D0 SE 0201661 A SE0201661 A SE 0201661A SE 0201661 A SE0201661 A SE 0201661A SE 0201661 D0 SE0201661 D0 SE 0201661D0
- Authority
- SE
- Sweden
- Prior art keywords
- acid addition
- addition salt
- salts
- thrombin
- new salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (37)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0201661A SE0201661D0 (sv) | 2002-05-31 | 2002-05-31 | New salts |
DE60326720T DE60326720D1 (de) | 2002-05-31 | 2003-05-27 | Sulfonsäuresalze von Mandelsäurederivaten |
CA002487509A CA2487509A1 (en) | 2002-05-31 | 2003-05-27 | New salts |
MXPA04011912A MXPA04011912A (es) | 2002-05-31 | 2003-05-27 | Sales nuevas. |
AU2003232871A AU2003232871B2 (en) | 2002-05-31 | 2003-05-27 | New salts |
NZ554323A NZ554323A (en) | 2002-05-31 | 2003-05-27 | Pharmaceutically-acceptable acid addition salts of certain methoxy-and ethoxy-amidine compounds, pharmaceutical formulations containing such salts, and processes for obtaining them |
PL03373794A PL373794A1 (en) | 2002-05-31 | 2003-05-27 | New salts |
JP2004509651A JP4541140B2 (ja) | 2002-05-31 | 2003-05-27 | 新塩類 |
US10/516,422 US7273858B2 (en) | 2002-05-31 | 2003-05-27 | Salts |
KR10-2004-7019439A KR20050009726A (ko) | 2002-05-31 | 2003-05-27 | 신규 염 |
EP09151657A EP2055696A1 (de) | 2002-05-31 | 2003-05-27 | Säureadditionssalze von Mandelsäurederivaten |
PCT/SE2003/000859 WO2003101957A1 (en) | 2002-05-31 | 2003-05-27 | New salts |
CN200910260483A CN101735131A (zh) | 2002-05-31 | 2003-05-27 | 新的盐 |
IL16529503A IL165295A0 (en) | 2002-05-31 | 2003-05-27 | Salts of compounds that inhibit thrombin followingadministration to mammalian patients, pharmaceuti cal compositions containing such salts and processes for obtaining them |
UA20041109441A UA81246C2 (en) | 2002-05-31 | 2003-05-27 | Salts of mandelic acid derivatives |
RU2004133388/04A RU2345064C2 (ru) | 2002-05-31 | 2003-05-27 | Фармацевтически приемлемые соли присоединения сульфоновой кислоты метоксиамидинового соединения и способ их получения |
ES03728206T ES2322048T3 (es) | 2002-05-31 | 2003-05-27 | Sales de acido sulfonico de derivados de acido mandelico. |
EP03728206A EP1513806B1 (de) | 2002-05-31 | 2003-05-27 | Sulfonsäuresalze von Mandelsäurederivaten |
AT03728206T ATE425963T1 (de) | 2002-05-31 | 2003-05-27 | Sulfonsauresalze von mandelsaurederivaten |
SI200331578T SI1513806T1 (sl) | 2002-05-31 | 2003-05-27 | Sulfonske kislinske soli derivatov mandljeve kisline |
PT03728206T PT1513806E (pt) | 2002-05-31 | 2003-05-27 | Sais de ácido sulfónico de derivados do ácido mandélico |
CNA038124912A CN1656067A (zh) | 2002-05-31 | 2003-05-27 | 新的盐 |
DK03728206T DK1513806T3 (da) | 2002-05-31 | 2003-05-27 | Sulfonsyresalte af sulfonsyrederivater |
BR0311365-5A BR0311365A (pt) | 2002-05-31 | 2003-05-27 | Sal de adição de ácido farmaceuticamente aceitável, processo para a preparação de um sal de adição de ácido formulação farmacêutica, uso de um sal de adição de ácido, e, método de tratamento de uma condição onde a inibição da trombina é requerida |
NZ536738A NZ536738A (en) | 2002-05-31 | 2003-05-27 | Pharmaceutically-acceptable acid addition salts of certain methoxy- and ethoxy- amidine compounds, pharmaceutical formulations containing such salts and processes for obtaining them |
MYPI20031981A MY133333A (en) | 2002-05-31 | 2003-05-29 | New salts |
ARP030101935A AR039937A1 (es) | 2002-05-31 | 2003-05-30 | Derivados de azetidina como inhibidores de tripsina proteasas |
TW092114807A TWI313173B (en) | 2002-05-31 | 2003-05-30 | New salts |
TW097151265A TWI367754B (en) | 2002-05-31 | 2003-05-30 | New carboxamide compound |
SA3240440A SA03240440B1 (ar) | 2002-05-31 | 2003-12-10 | أملاح حمض مضافة مقبولة صيدلانيا من مركبات معينة من ميثوكسي methoxy وايثوكسي ethoxy اميدين amidine وعمليات الحصول عليها |
NO20044867A NO329064B1 (no) | 2002-05-31 | 2004-11-09 | Syreaddisjonssalter, fremstilling av slike, farmasoytiske preparater omfattende slike samt slike forbindelser for behandling av sykdom |
ZA200409228A ZA200409228B (en) | 2002-05-31 | 2004-11-17 | New salts. |
IS7598A IS7598A (is) | 2002-05-31 | 2004-12-15 | Ný sölt |
HK05105118.1A HK1073102A1 (en) | 2002-05-31 | 2005-06-20 | Sulphonic acid salts of mandelic acid derivatives |
US11/839,842 US7763597B2 (en) | 2002-05-31 | 2007-08-16 | Salts |
RU2008127541/04A RU2008127541A (ru) | 2002-05-31 | 2008-07-09 | Новые соли |
CY20091100535T CY1109085T1 (el) | 2002-05-31 | 2009-05-20 | Νεα αλατα |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0201661A SE0201661D0 (sv) | 2002-05-31 | 2002-05-31 | New salts |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0201661D0 true SE0201661D0 (sv) | 2002-05-31 |
Family
ID=20288039
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0201661A SE0201661D0 (sv) | 2002-05-31 | 2002-05-31 | New salts |
Country Status (31)
Country | Link |
---|---|
US (2) | US7273858B2 (de) |
EP (2) | EP1513806B1 (de) |
JP (1) | JP4541140B2 (de) |
KR (1) | KR20050009726A (de) |
CN (2) | CN101735131A (de) |
AR (1) | AR039937A1 (de) |
AT (1) | ATE425963T1 (de) |
AU (1) | AU2003232871B2 (de) |
BR (1) | BR0311365A (de) |
CA (1) | CA2487509A1 (de) |
CY (1) | CY1109085T1 (de) |
DE (1) | DE60326720D1 (de) |
DK (1) | DK1513806T3 (de) |
ES (1) | ES2322048T3 (de) |
HK (1) | HK1073102A1 (de) |
IL (1) | IL165295A0 (de) |
IS (1) | IS7598A (de) |
MX (1) | MXPA04011912A (de) |
MY (1) | MY133333A (de) |
NO (1) | NO329064B1 (de) |
NZ (2) | NZ536738A (de) |
PL (1) | PL373794A1 (de) |
PT (1) | PT1513806E (de) |
RU (2) | RU2345064C2 (de) |
SA (1) | SA03240440B1 (de) |
SE (1) | SE0201661D0 (de) |
SI (1) | SI1513806T1 (de) |
TW (2) | TWI367754B (de) |
UA (1) | UA81246C2 (de) |
WO (1) | WO2003101957A1 (de) |
ZA (1) | ZA200409228B (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR035216A1 (es) * | 2000-12-01 | 2004-05-05 | Astrazeneca Ab | Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios |
AR034517A1 (es) | 2001-06-21 | 2004-02-25 | Astrazeneca Ab | Formulacion farmaceutica |
SE0201659D0 (sv) | 2002-05-31 | 2002-05-31 | Astrazeneca Ab | Modified release pharmaceutical formulation |
SE0201661D0 (sv) * | 2002-05-31 | 2002-05-31 | Astrazeneca Ab | New salts |
US7781424B2 (en) * | 2003-05-27 | 2010-08-24 | Astrazeneca Ab | Modified release pharmaceutical formulation |
JP4550884B2 (ja) * | 2004-04-09 | 2010-09-22 | ハンミ ファーム. シーオー., エルティーディー. | 結晶性クロピドグレルナフタレンスルホン酸塩又はその水和物、その製造方法及びそれを含む医薬組成物 |
EA010829B1 (ru) * | 2004-04-20 | 2008-12-30 | Санофи-Авентис | Клопидогрель и его полиморфные формы |
TW200827336A (en) * | 2006-12-06 | 2008-07-01 | Astrazeneca Ab | New crystalline forms |
TW200900033A (en) * | 2007-06-21 | 2009-01-01 | Wen-Qing Li | Automatic brewing machine |
US20090061000A1 (en) * | 2007-08-31 | 2009-03-05 | Astrazeneca Ab | Pharmaceutical formulation use 030 |
Family Cites Families (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU178398B (en) | 1979-06-12 | 1982-04-28 | Gyogyszerkutato Intezet | Process for producing new agmatine derivatives of activity against haemagglutination |
JPS57149217A (en) | 1981-03-11 | 1982-09-14 | Kaken Pharmaceut Co Ltd | Slow-releasing pharmaceutical preparation |
HU192646B (en) | 1984-12-21 | 1987-06-29 | Gyogyszerkutato Intezet | Process for preparing new n-alkyl-peptide aldehydes |
AU600226B2 (en) | 1985-02-04 | 1990-08-09 | Merrell Pharmaceuticals Inc. | Novel peptidase inhibitors |
US5187157A (en) | 1987-06-05 | 1993-02-16 | Du Pont Merck Pharmaceutical Company | Peptide boronic acid inhibitors of trypsin-like proteases |
US4792452A (en) | 1987-07-28 | 1988-12-20 | E. R. Squibb & Sons, Inc. | Controlled release formulation |
EP0362002B1 (de) | 1988-09-01 | 1995-07-26 | Merrell Dow Pharmaceuticals Inc. | HIV Protease-Hemmer |
ZA897515B (en) | 1988-10-07 | 1990-06-27 | Merrell Dow Pharma | Novel peptidase inhibitors |
IT1229491B (it) | 1988-12-28 | 1991-09-03 | Roussel Maestretti S P A Ora R | Derivati della 1,2,5,6-tetraidropiridina, loro procedimento di preparazione e loro impiego come sostanze medicinali |
TW201303B (de) | 1990-07-05 | 1993-03-01 | Hoffmann La Roche | |
CA2075154A1 (en) | 1991-08-06 | 1993-02-07 | Neelakantan Balasubramanian | Peptide aldehydes as antithrombotic agents |
SE9102462D0 (sv) | 1991-08-28 | 1991-08-28 | Astra Ab | New isosteric peptides |
US5169638A (en) | 1991-10-23 | 1992-12-08 | E. R. Squibb & Sons, Inc. | Buoyant controlled release powder formulation |
CZ333492A3 (en) | 1991-11-12 | 1993-09-15 | Lilly Co Eli | Dipeptide of l-azetidine-2-carboxylic acids and l-argininaldehyde, process of its preparation and pharmaceutical preparation in which said dipeptide is comprised |
SE9103612D0 (sv) | 1991-12-04 | 1991-12-04 | Astra Ab | New peptide derivatives |
EP0629212B1 (de) | 1992-03-04 | 1997-10-08 | Gyogyszerkutato Intezet Kft. | Neuartige antikoagulierende peptidderivate und arzneimittel die solche enthalten so wie entsprechendes herstellungsverfahren |
TW223629B (de) | 1992-03-06 | 1994-05-11 | Hoffmann La Roche | |
US5783563A (en) | 1993-06-03 | 1998-07-21 | Astra Aktiebolag | Method for treatment or prophylaxis of venous thrombosis |
US6984627B1 (en) | 1993-06-03 | 2006-01-10 | Astrazeneca Ab | Peptide derivatives |
SE9301916D0 (sv) | 1993-06-03 | 1993-06-03 | Ab Astra | New peptides derivatives |
SE9301912D0 (sv) | 1993-06-03 | 1993-06-03 | Ab Astra | Process for the production of aminoalkylguandines |
EP0648780A1 (de) | 1993-08-26 | 1995-04-19 | Bristol-Myers Squibb Company | Heterozyklische Thrombinhemmer |
TW394760B (en) | 1993-09-07 | 2000-06-21 | Hoffmann La Roche | Novel Carboxamides, process for their preparation and pharmaceutical composition containing the same |
AU1025795A (en) | 1994-01-27 | 1995-08-03 | Mitsubishi Chemical Corporation | Prolineamide derivatives |
IL112795A (en) | 1994-03-04 | 2001-01-28 | Astrazeneca Ab | Derivatives of peptides as antithrombotic drugs, their preparation, and pharmaceutical preparations containing them |
US5705487A (en) | 1994-03-04 | 1998-01-06 | Eli Lilly And Company | Antithrombotic agents |
US5707966A (en) | 1994-03-04 | 1998-01-13 | Eli Lilly And Company | Antithrombotic agents |
US5561146A (en) | 1994-06-10 | 1996-10-01 | Bristol-Myers Squibb Company | Modified guanidino and amidino thrombin inhibitors |
DE4421052A1 (de) | 1994-06-17 | 1995-12-21 | Basf Ag | Neue Thrombininhibitoren, ihre Herstellung und Verwendung |
US5498724A (en) | 1994-06-28 | 1996-03-12 | Aktiebolaget Astra | Pyrazoleamidine compounds |
US5510369A (en) | 1994-07-22 | 1996-04-23 | Merck & Co., Inc. | Pyrrolidine thrombin inhibitors |
JPH11500120A (ja) | 1995-02-17 | 1999-01-06 | ビーエーエスエフ アクチェンゲゼルシャフト | 新規なトロンビンインヒビター |
US5710130A (en) | 1995-02-27 | 1998-01-20 | Eli Lilly And Company | Antithrombotic agents |
US6083532A (en) | 1995-03-01 | 2000-07-04 | Duramed Pharmaceuticals, Inc. | Sustained release formulation containing three different types of polymers and tablet formed therefrom |
US5695781A (en) | 1995-03-01 | 1997-12-09 | Hallmark Pharmaceuticals, Inc. | Sustained release formulation containing three different types of polymers |
AU698911B2 (en) | 1995-04-04 | 1998-11-12 | Merck & Co., Inc. | Thrombin inhibitors |
US5629324A (en) | 1995-04-10 | 1997-05-13 | Merck & Co., Inc. | Thrombin inhibitors |
SA96170106A (ar) | 1995-07-06 | 2005-12-03 | أسترا أكتيبولاج | مشتقات حامض أميني جديدة |
TWI238827B (en) | 1995-12-21 | 2005-09-01 | Astrazeneca Ab | Prodrugs of thrombin inhibitors |
SE9601556D0 (sv) | 1996-04-24 | 1996-04-24 | Astra Ab | New pharmaceutical formulation of a thrombin inhibitor for parenteral use |
SE9602263D0 (sv) | 1996-06-07 | 1996-06-07 | Astra Ab | New amino acid derivatives |
US5863929A (en) | 1996-06-25 | 1999-01-26 | Eli Lilly And Company | Anticoagulant agents |
SE9602646D0 (sv) | 1996-07-04 | 1996-07-04 | Astra Ab | Pharmaceutically-useful compounds |
DE19632772A1 (de) | 1996-08-14 | 1998-02-19 | Basf Ag | Neue Benzamidine |
SE9603724D0 (sv) | 1996-10-11 | 1996-10-11 | Astra Ab | New pharmaceutical parenteral formulation of a thrombin inhibitor |
AR013084A1 (es) | 1997-06-19 | 2000-12-13 | Astrazeneca Ab | Derivados de amidino utiles como inhibidores de la trombina, composicion farmaceutica, utilizacion de dichos compuestos para la preparacion demedicamentos y proceso para la preparacion de los compuestos mencionados |
IT1297461B1 (it) | 1997-10-29 | 1999-12-17 | Ciocca Maurizio | Preparazione di compresse a rilascio controllato a base di complessi tra carragenano e farmaci basici solubili |
SE9704543D0 (sv) | 1997-12-05 | 1997-12-05 | Astra Ab | New compounds |
US6251430B1 (en) | 1998-02-04 | 2001-06-26 | Guohua Zhang | Water insoluble polymer based sustained release formulation |
US6174913B1 (en) | 1998-06-05 | 2001-01-16 | The University Of North Carolina At Chapel Hill | Naphtho- and dihydrobenzo-thiophene derivatives as cytotoxic antitumor agents |
SE9802938D0 (sv) | 1998-09-01 | 1998-09-01 | Astra Ab | Improved stability for injection solutions |
SE9802973D0 (sv) | 1998-09-03 | 1998-09-03 | Astra Ab | Immediate release tablet |
SE9802974D0 (sv) | 1998-09-03 | 1998-09-03 | Astra Ab | New crystalline forms |
ATE363292T1 (de) | 1998-09-04 | 2007-06-15 | Scios Inc | Hydrogelzusammensetzungen mit kontrollierter freigabe von wachstumsfaktoren |
SE9804313D0 (sv) | 1998-12-14 | 1998-12-14 | Astra Ab | New compounds |
DE60037183T2 (de) | 1999-01-13 | 2008-10-09 | Astrazeneca Ab | Neue amidinbenzylamin-derivate und ihre verwendung als thrombin-inhibitoren |
SE9902550D0 (sv) | 1999-07-02 | 1999-07-02 | Astra Ab | New crystalline forms |
SE0001803D0 (sv) | 2000-05-16 | 2000-05-16 | Astrazeneca Ab | New compounds i |
PT1311480E (pt) * | 2000-08-16 | 2008-11-11 | Astrazeneca Ab | Novos derivados amidino e sua utilização como inibidores da trombina |
US6433186B1 (en) | 2000-08-16 | 2002-08-13 | Astrazeneca Ab | Amidino derivatives and their use as thormbin inhibitors |
SE0102921D0 (sv) | 2001-08-30 | 2001-08-30 | Astrazeneca Ab | Pharmaceutically useful compounds |
AR035216A1 (es) | 2000-12-01 | 2004-05-05 | Astrazeneca Ab | Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios |
US7129233B2 (en) * | 2000-12-01 | 2006-10-31 | Astrazeneca Ab | Mandelic acid derivatives and their use as thrombin inhibitors |
US6287599B1 (en) | 2000-12-20 | 2001-09-11 | Shire Laboratories, Inc. | Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles |
AR034517A1 (es) * | 2001-06-21 | 2004-02-25 | Astrazeneca Ab | Formulacion farmaceutica |
US6811794B2 (en) | 2001-12-20 | 2004-11-02 | Shire Laboratories, Inc. | Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles |
SE0201658D0 (sv) * | 2002-05-31 | 2002-05-31 | Astrazeneca Ab | Immediate release pharmaceutical formulation |
SE0201661D0 (sv) | 2002-05-31 | 2002-05-31 | Astrazeneca Ab | New salts |
SE0201659D0 (sv) * | 2002-05-31 | 2002-05-31 | Astrazeneca Ab | Modified release pharmaceutical formulation |
US7781424B2 (en) | 2003-05-27 | 2010-08-24 | Astrazeneca Ab | Modified release pharmaceutical formulation |
SE0303220D0 (sv) | 2003-11-28 | 2003-11-28 | Astrazeneca Ab | New process |
GB0503672D0 (en) | 2005-02-23 | 2005-03-30 | Astrazeneca Ab | New process |
GB0510546D0 (en) | 2005-05-24 | 2005-06-29 | Astrazeneca Ab | New process |
TW200827336A (en) | 2006-12-06 | 2008-07-01 | Astrazeneca Ab | New crystalline forms |
-
2002
- 2002-05-31 SE SE0201661A patent/SE0201661D0/xx unknown
-
2003
- 2003-05-27 ES ES03728206T patent/ES2322048T3/es not_active Expired - Lifetime
- 2003-05-27 BR BR0311365-5A patent/BR0311365A/pt not_active IP Right Cessation
- 2003-05-27 DK DK03728206T patent/DK1513806T3/da active
- 2003-05-27 AU AU2003232871A patent/AU2003232871B2/en not_active Ceased
- 2003-05-27 EP EP03728206A patent/EP1513806B1/de not_active Expired - Lifetime
- 2003-05-27 PT PT03728206T patent/PT1513806E/pt unknown
- 2003-05-27 JP JP2004509651A patent/JP4541140B2/ja not_active Expired - Fee Related
- 2003-05-27 NZ NZ536738A patent/NZ536738A/en not_active IP Right Cessation
- 2003-05-27 EP EP09151657A patent/EP2055696A1/de not_active Withdrawn
- 2003-05-27 CA CA002487509A patent/CA2487509A1/en not_active Abandoned
- 2003-05-27 PL PL03373794A patent/PL373794A1/xx not_active Application Discontinuation
- 2003-05-27 MX MXPA04011912A patent/MXPA04011912A/es active IP Right Grant
- 2003-05-27 NZ NZ554323A patent/NZ554323A/en not_active IP Right Cessation
- 2003-05-27 DE DE60326720T patent/DE60326720D1/de not_active Expired - Lifetime
- 2003-05-27 RU RU2004133388/04A patent/RU2345064C2/ru not_active IP Right Cessation
- 2003-05-27 IL IL16529503A patent/IL165295A0/xx unknown
- 2003-05-27 CN CN200910260483A patent/CN101735131A/zh active Pending
- 2003-05-27 AT AT03728206T patent/ATE425963T1/de not_active IP Right Cessation
- 2003-05-27 CN CNA038124912A patent/CN1656067A/zh active Pending
- 2003-05-27 KR KR10-2004-7019439A patent/KR20050009726A/ko not_active Application Discontinuation
- 2003-05-27 WO PCT/SE2003/000859 patent/WO2003101957A1/en active Application Filing
- 2003-05-27 SI SI200331578T patent/SI1513806T1/sl unknown
- 2003-05-27 US US10/516,422 patent/US7273858B2/en not_active Expired - Fee Related
- 2003-05-27 UA UA20041109441A patent/UA81246C2/uk unknown
- 2003-05-29 MY MYPI20031981A patent/MY133333A/en unknown
- 2003-05-30 AR ARP030101935A patent/AR039937A1/es unknown
- 2003-05-30 TW TW097151265A patent/TWI367754B/zh not_active IP Right Cessation
- 2003-05-30 TW TW092114807A patent/TWI313173B/zh active
- 2003-12-10 SA SA3240440A patent/SA03240440B1/ar unknown
-
2004
- 2004-11-09 NO NO20044867A patent/NO329064B1/no not_active IP Right Cessation
- 2004-11-17 ZA ZA200409228A patent/ZA200409228B/en unknown
- 2004-12-15 IS IS7598A patent/IS7598A/is unknown
-
2005
- 2005-06-20 HK HK05105118.1A patent/HK1073102A1/xx not_active IP Right Cessation
-
2007
- 2007-08-16 US US11/839,842 patent/US7763597B2/en not_active Expired - Fee Related
-
2008
- 2008-07-09 RU RU2008127541/04A patent/RU2008127541A/ru not_active Application Discontinuation
-
2009
- 2009-05-20 CY CY20091100535T patent/CY1109085T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0100902D0 (sv) | Compounds | |
ATE238279T1 (de) | Zyklische aminoverbindungen | |
DE69809187D1 (de) | Metalloproteinase-Inhibitoren | |
CY1109085T1 (el) | Νεα αλατα | |
DK1120388T3 (da) | Anvendelse af pyrazolderivater som nitrifikationsinhibitor | |
AR029696A1 (es) | Derivados de ciclopentil-glutaramida como inhibidores de endopeptidasa neutra | |
CY1113657T1 (el) | Νεα παραγωγα βενζοφαινονης ή αλατα αυτων | |
ATE431827T1 (de) | Phosphonocephem-verbindung | |
DE60317198D1 (de) | Proteinkinaseinhibitoren | |
IS7841A (is) | Efnafræðilegt milliefni | |
NO20012914L (no) | Nye amidinoderivater og deres anvendelse som trombininhibitorer | |
NO20061302L (no) | Derivater av hydroksaminsyre som metalloproteinseinbitorer | |
SE0102921D0 (sv) | Pharmaceutically useful compounds | |
DK1311480T3 (da) | Nye amidinoderivater og deres anvendelse som thrambininhibitor | |
DK1637141T3 (da) | Stabiliseret proteasesammensætning omfattende en serinprotease, morpholinderivater og reversible inhibitorer af serinproteasen | |
NO20040813L (no) | Nye mandelsyre derivater og anvendelse derav som trombin inhibitorer. | |
UY28102A1 (es) | Nuevas sales | |
TWI264434B (en) | New mandelic acid derivatives and their use as thrombin inhibitors | |
GT200300192A (es) | Inhibidores de factor xa y otras serinaproteasas implicadas en la cascada de la coagulacion | |
TH98266B (th) | เกลือชนิดใหม่ | |
TH98266A (th) | เกลือชนิดใหม่ | |
ECSP034417A (es) | Derivados de ciclopentil-glutaramida como inhibidores de endopeptidasa neutra | |
SE0201005D0 (sv) | New Process |